| Literature DB >> 22606331 |
Zhi Liu1, Jie Zhao, Yunhe Li, Wenwei Zhang, Guiliang Jian, Yufa Peng, Fangjun Qi.
Abstract
DNA microarray analysis is an effective method to detect unintended effects by detecting differentially expressed genes (DEG) in safety assessment of genetically modified (GM) crops. With the aim to reveal the distribution of DEG of GM crops under different conditions, we performed DNA microarray analysis using transgenic rice Huahui 1 (HH1) and its non-transgenic parent Minghui 63 (MH63) at different developmental stages and environmental conditions. Considerable DEG were selected in each group of HH1 under different conditions. For each group of HH1, the number of DEG was different; however, considerable common DEG were shared between different groups of HH1. These findings suggested that both DEG and common DEG were adequate for investigation of unintended effects. Furthermore, a number of significantly changed pathways were found in all groups of HH1, indicating genetic modification caused everlasting changes to plants. To our knowledge, our study for the first time provided the non-uniformly distributed pattern for DEG of GM crops at different developmental stages and environments. Our result also suggested that DEG selected in GM plants at specific developmental stage and environment could act as useful clues for further evaluation of unintended effects of GM plants.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22606331 PMCID: PMC3350509 DOI: 10.1371/journal.pone.0037078
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number of DEP on each rice chromosome in HH1 at different developmental stages and environments.
| Chr1 | Chr2 | Chr3 | Chr4 | Chr5 | Chr6 | Chr7 | Chr8 | Chr9 | Chr10 | Chr11 | Chr12 | |
|
| 49 | 28 | 26 | 20 | 27 | 16 | 22 | 13 | 18 | 7 | 33 | 10 |
|
| 13 | 9 | 6 | 5 | 10 | 3 | 17 | 4 | 15 | 4 | 34 | 4 |
|
| 45 | 19 | 24 | 16 | 24 | 21 | 36 | 19 | 31 | 9 | 30 | 8 |
|
| 27 | 15 | 16 | 8 | 21 | 8 | 23 | 2 | 14 | 4 | 30 | 8 |
|
| 67 | 39 | 49 | 32 | 34 | 26 | 51 | 17 | 41 | 23 | 43 | 18 |
|
| 24 | 15 | 17 | 14 | 21 | 6 | 29 | 15 | 16 | 8 | 31 | 5 |
|
| 19 | 17 | 19 | 14 | 14 | 8 | 27 | 10 | 23 | 8 | 37 | 7 |
|
| 54 | 34 | 51 | 36 | 34 | 19 | 37 | 19 | 34 | 10 | 45 | 13 |
|
| 14 | 12 | 17 | 12 | 12 | 4 | 22 | 6 | 19 | 2 | 31 | 5 |
|
| 13 | 14 | 15 | 7 | 18 | 6 | 27 | 4 | 22 | 3 | 34 | 3 |
Numbers of DEP and DEG in HH1 compared with MH63 at different developmental stages and environments.
| Treatments | Developmental stage | Temperature stress | Pathogen inoculation | |||||||
| 30 d | 60 d | 75 d | 90 d | HT | LT | JxoI | Pxo99 | Rs105 | Xv5 | |
|
| 271 | 177 | 442 | 203 | 125 | 283 | 207 | 389 | 157 | 168 |
|
| 261 | 167 | 422 | 195 | 116 | 271 | 194 | 372 | 148 | 157 |
Figure 1Volcano plots for differentially expressed genes in HH1.
Each point represents a gene detected in microarray analysis. Red spots represent differentially expressed genes with fold change ≥2.0; green spots represent differentially expressed genes with fold change ≤0.5. The log2 (ratio) of expression (HH1/MH63) is shown on the X-axis and the –lg (p-value) is shown on the Y-axis. The vertical lines represent 2-fold change ratio and the horizontal line represents statistical-significance level where p = 0.05. 30-day, 60-day, 75-day, 90-day: HH1 and MH63 at developmental stage of 30-day, 60-day, 75-day, 90-day, respectively; HT: HH1 and MH63 treated with high-temperature at 45°C for 6 hours; LT: HH1 and MH63 treated with low-temperature at 12°C for 6 hours; JxoI, Pxo99: HH1 and MH63 inoculated with X. oryzae pv. oryzae JxoI and Pxo99 strain; Rs105: HH1 and MH63 inoculated with X. oryzae pv. oryzicola Rs105 strain; Xv5: HH1 and MH63 inoculated with non-host pathogen X. compestris pv. vesicatoria Xv5 strain.
Figure 2Distribution patterns of common DEP of HH1 in pairwise comparison.
Pairwise comparisons were carried out between groups of DEP of HH1 at different developmental stages and environments. Ratio of number of common DEP to number of the smaller group of DEP in the pairwise comparison was calculated and represented by different colors: ▪- 25∼50%, ▪- 50∼75%, ▪- 75∼100%. ▪represents numbers of DEP in HH1. 30-day, 60-day, 75-day, 90-day: HH1 and MH63 at developmental stage of 30-day, 60-day, 75-day, 90-day, respectively; HT: HH1 and MH63 treated with high-temperature at 45°C for 6 hours; LT: HH1 and MH63 treated with low-temperature at 12°C for 6 hours; JxoI, Pxo99: HH1 and MH63 inoculated with X. oryzae pv. oryzae JxoI and Pxo99 strain; Rs105: HH1 and MH63 inoculated with X. oryzae pv. oryzicola Rs105 strain; Xv5: HH1 and MH63 inoculated with non-host pathogen X. compestris pv. vesicatoria Xv5 strain.
Common significantly changed pathways of HH1 at different developmental stages and environments.
| Pathway name |
| |||||||||
| 30-day | HT | LT | 60-day | 75-day | 90-day | JxoI | Pxo99 | Rs105 | Xv5 | |
| jasmonic acid biosynthesis | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| enterobactin biosynthesis | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| sucrose degradation to ethanol and lactate (anaerobic) | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| oxidative ethanol degradation I | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| phenylalanine degradation III | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| methionine degradation III | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| ethanol fermentation to acetate | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| valine degradation II | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| tetrapyrrole biosynthesis I | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| leucine degradation III | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| mixed acid fermentation | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| isoleucine degradation II | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| cytokinins 7-N-glucoside biosynthesis | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| cytokinins 9-N-glucoside biosynthesis | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| betanidin degradation | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| cytokinins-O-glucoside biosynthesis | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| aerobic respiration – electron donor II | √ | √ | √ | √ | X | √ | √ | √ | √ | √ |
| photorespiration | √ | X | √ | √ | √ | √ | √ | √ | √ | √ |
| NAD salvage pathway II | √ | √ | √ | √ | √ | X | √ | √ | X | √ |
| brassinosteroid biosynthesis II | √ | √ | √ | √ | √ | √ | X | √ | X | √ |
| medicarpin biosynthesis | √ | X | X | √ | √ | √ | X | √ | X | √ |
| maackiain biosynthesis | √ | X | X | √ | √ | √ | X | √ | X | √ |
| cellulose biosynthesis | X | √ | X | X | √ | √ | √ | √ | √ | X |
| starch degradation | X | X | X | X | √ | √ | √ | √ | √ | √ |
30-day, 60-day, 75-day, 90-day: HH1 and MH63 at developmental stage of 30-day, 60-day, 75-day, 90-day, respectively; HT: HH1 and MH63 treated with high-temperature at 45°C for 6 hours; LT: HH1 and MH63 treated with low-temperature at 12°C for 6 hours; JxoI, Pxo99: HH1 and MH63 inoculated with X. oryzae pv. oryzae JxoI and Pxo99 strain; Rs105: HH1 and MH63 inoculated with X. oryzae pv. oryzicola Rs105 strain; Xv5: HH1 and MH63 inoculated with non-host pathogen X. compestris pv. vesicatoria Xv5 strain. √: detected; X: not found (For detailed information, please refer to Table S3).